Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2019
Canadian public places high priority on drugs’ safety, effectiveness, and certainty of evidence
25 March 2019 - Survey reveals top values for drug coverage decision making. ...
Posted by Michael Wonder on 25 Mar 2019
One Canadian payer's experience with biosimilars
25 March 2019 - Much of the discussion about biosimilar uptake revolves around challenges in the United States, but other ...
Posted by Michael Wonder on 23 Mar 2019
A patient’s journey with melanoma and drug coverage concerns
22 March 2019 - Living her best life with her husband Jeremy, Karen Formosa was looking forward to retiring within ...
Posted by Michael Wonder on 22 Mar 2019
Ontario may lift ban preventing major pharmacies from selling private-label generic drugs
21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...
Posted by Michael Wonder on 21 Mar 2019
Why Ontario parents could soon be paying more for prescription drugs
22 March 2019 - Some Ontario parents will be paying more for their kids’ medicine starting next month. Young adults ...
Posted by Michael Wonder on 20 Mar 2019
Where is the champion for Pharmacare?
20 March 2019 - With the possible exception of a few drug company executives, Canadians overwhelmingly support universal pharmacare — ...
Posted by Michael Wonder on 20 Mar 2019
National drug agency touted as building block of Pharmacare plan
19 March 2019 - The Trudeau Liberals’ new budget promises a new agency to buy drugs in bulk and cut ...
Posted by Michael Wonder on 20 Mar 2019
Roche and the pan-Canadian Pharmaceutical Alliance complete negotiations for multiple sclerosis treatment, Ocrevus (ocrelizumab), for both RRMS and PPMS
19 March 2019 - Roche Canada today announced that it has completed negotiations with the pan-Canadian Pharmaceutical Alliance for a ...
Posted by Michael Wonder on 20 Mar 2019
Canada to create national drug agency to help cut cost of medicines
20 March 2019 - Canada will create a national drug agency to help cut the cost of prescription medications as part ...
Posted by Michael Wonder on 19 Mar 2019
New treatment option now available in Canada for newly diagnosed patients with advanced lung cancer
18 March 2019 - Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy reduced the risk of death by half compared ...
Posted by Michael Wonder on 18 Mar 2019
The impact of pharmaceutical rebates on patients’ drug expenditures
18 March 2019 - The drug-pricing landscape in Canada is complex, with 4 different agencies and each provincial, territorial and federal ...
Posted by Michael Wonder on 15 Mar 2019
Health Canada begins release of clinical data on drugs and devices
14 March 2019 - Health Canada launched two public databases on Wednesday as the first step in making clinical information ...
Posted by Michael Wonder on 14 Mar 2019
The Liberals’ plan for Pharmacare? We’re still waiting
14 March 2019 - The Trudeau government is edging closer to announcing its proposals for some kind of national drug ...
Posted by Michael Wonder on 13 Mar 2019
Foquest receives approval for expanded indication for children and adolescents with ADHD
12 March 2019 - First and only methylphenidate product approved in Canada that provides control of ADHD symptoms throughout the day. ...
Posted by Michael Wonder on 11 Mar 2019
Imbruvica (ibrutinib) combination regimen to treat Waldenström's macroglobulinemia approved through Health Canada priority review
8 March 2019 - Imbruvica plus rituximab showed significant improvement in progression-free survival versus rituximab monotherapy in Waldenström's macroglobulinemia, a ...